Literature DB >> 184808

Solid tumour models for the assessment of different treatment modalities: IV. the combined effects of radiation and 5-fluorouracil.

W B Looney, J G Schaffner, J S Trefil, C J Kovacs, H A Hopkins.   

Abstract

Neither radiation alone (375 to 1500 rad) nor5-fluorouracil (FU) alone (50-250 mg/kg) is sufficient to prevent an increase in the volume of the solid tumour model hepatoma 3924A. However, as little as 750 rad with 100 mg/kg FU can reduce the tumour below the volume at the time of treatment for as long as 14 days. A series of combined FU and radiation doses given every 11 days should then result in successively smaller tumour volumes until the tumour is eradicated. Changes in tumour volume were analysed by two different methods: (1) tumours in each treatment mode were grouped together and the average response to treatment determined, and (2) tumour volume changes in individual tumours were analyzed utilizing the chi2 technique, which fits the logarithmic tumour volume change with time to polynomials. This two-directional method of analysis has the advantage of permitting both an overview of the main effects of treatment via the averages, and at the same time a detailed examination of the mechanism by which these effects occur through the analysis of individual response. The results suggest that, in addition to concentrating on the cellular response immediately after therapy, greater emphasis should be placed on the kinetic changes of the tumour 1-3 weeks after single or multiple modality therapy. These findings demonstrate how the sequencing of single and/or combined treatment modalities may be investigated in order to detemine how best to obtain maximum effects of treatment on different types of tumours following recovery of the host from the previous treatment series.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184808      PMCID: PMC2025176          DOI: 10.1038/bjc.1976.160

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

Review 1.  Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer.

Authors:  V T DeVita; R C Young; G P Canellos
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

2.  Cell proliferation and tumor growth in hepatomas 3924A.

Authors:  W B Looney; A A Mayo; M Y Janners; J G Mellon; P Allen; D Salak; H P Morris
Journal:  Cancer Res       Date:  1971-06       Impact factor: 12.701

3.  Combination therapy with drugs and radiation.

Authors:  N M Bleehen
Journal:  Br Med Bull       Date:  1973-01       Impact factor: 4.291

4.  The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy.

Authors:  S A Rosenberg; H S Kaplan
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

5.  Solid tumor models for the assessment of different treatment modalities: I. Radiation-induced changes in growth rate characteristics of a solid tumor model.

Authors:  W B Looney; J S Trefil; J C Schaffner; C J Kovacs; H A Hopkins
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

6.  Solid tumor models for the assessment of different treatment modalities: systematics of response to radiotherapy and chemotherapy.

Authors:  W B Looney; J S Trefil; J G Schaffner; C J Kovacs; H A Hopkins
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

7.  Characterization of growth properties and demonstration of the tumor-specific transplantation antigens of Morris hepatomas.

Authors:  H T Wepsic; R Nickel; J Alaimo
Journal:  Cancer Res       Date:  1976-01       Impact factor: 12.701

8.  End results of radiation therapy, alone and combination with 5-fluorouracil in colorectal cancers.

Authors:  V Vongtama; H O Douglass; R H Moore; E D Holyoke; J H Webster
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

9.  A mathematical evaluation of tumour growth curves in rapid, intermediate and slow growing rat hepatomata.

Authors:  W B Looney; A A Mayo; P M Allen; J Y Morrow; H P Morris
Journal:  Br J Cancer       Date:  1973-04       Impact factor: 7.640

10.  Effects of 5-fluorouracil on the cell kinetic and growth parameters of hepatoma 3924A.

Authors:  C J Kovacs; H A Hopkins; R M Simon; W B Looney
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

View more
  4 in total

1.  Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexate.

Authors:  P A Volberding; M A Friedman; K J Resser; T L Phillips
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Solid tumor models for assessment of different treatment modalities: therapeutic strategy for sequential chemotherapy with radiotherapy.

Authors:  W B Looney; J S Trefil; H A Hopkins; C J Kovacs; R Ritenour; J G Schaffner
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

3.  Toxicity of 5-fluorouracil for aerobic and hypoxic cells in two murine tumours.

Authors:  I F Tannock
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  Solid tumour models for the assessment of different treatment modalities: VII: single vs fractionated doses of 5-fluorouracil on two solid tumours and their hosts.

Authors:  W B Looney; M S Macleod; H A Hopkins
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.